Clinical Research Directory

Breast Cancer Subtype Characterization Through Patient's Derived Organoids.

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Summary

Development of tools to predict patients chemo-sensitivity and identification of corresponding biomarkers is an urgent challenge for BC patients lacking targeted therapies, such as TNBC, or for patients experiencing relapse after adjuvant chemotherapy or targeted therapies. The refinement of 3D-cultivation techniques, experienced in the last decade, has allowed cultivation of patients-derived cancer cells in organotypic structures, named patient-derived organoids (PDO), which preserve histologic, genomic and transcriptomic features of primary tumors. PDO allow propagation, pharmacological treatment and genetic manipulation of patients-derived cancer cells in a close to physiology setting, thus representing a promising tool in the development of personalized therapies

Official title: Breast Cancer Subtype Characterization Through Patient's Derived Organoids". (BCinsightPDO)

Key Details

Conditions

Locations (1)